Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Human cytomegalovirus inhibits apoptosis by regulating the activating transcription factor 5 signaling pathway in human malignant glioma cells.

Wang T, Qian D, Hu M, Li L, Zhang L, Chen H, Yang R, Wang B.

Oncol Lett. 2014 Sep;8(3):1051-1057. Epub 2014 Jun 18.

2.

Human cytomegalovirus infection promotes the stemness of U251 glioma cells.

Wang X, Hu M, Xing F, Wang M, Wang B, Qian D.

J Med Virol. 2017 May;89(5):878-886. doi: 10.1002/jmv.24708. Epub 2017 Feb 10.

PMID:
27714816
3.

Human cytomegalovirus immediate-early protein promotes survival of glioma cells through interacting and acetylating ATF5.

Hu M, Wang B, Qian D, Wang M, Huang R, Wei L, Li L, Zhang L, Liu DX.

Oncotarget. 2017 May 9;8(19):32157-32170. doi: 10.18632/oncotarget.17150.

4.

A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.

Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, Moser RP, Green MR.

Nat Med. 2010 Jun;16(6):671-7. doi: 10.1038/nm.2158. Epub 2010 May 23.

5.

Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma.

Huang R, Qian D, Hu M, Zhang X, Song J, Li L, Chen H, Wang B.

Oncol Lett. 2015 Nov;10(5):2812-2820. Epub 2015 Aug 25.

6.

Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.

Cobbs CS, Soroceanu L, Denham S, Zhang W, Kraus MH.

Cancer Res. 2008 Feb 1;68(3):724-30. doi: 10.1158/0008-5472.CAN-07-2291.

7.

HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation.

Li G, Xu Y, Guan D, Liu Z, Liu DX.

J Biol Chem. 2011 Jun 10;286(23):20251-9. doi: 10.1074/jbc.M110.211771. Epub 2011 Apr 25.

8.

Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways.

Shen YH, Utama B, Wang J, Raveendran M, Senthil D, Waldman WJ, Belcher JD, Vercellotti G, Martin D, Mitchelle BM, Wang XL.

Circ Res. 2004 May 28;94(10):1310-7. Epub 2004 Apr 22.

9.

BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.

Dluzen D, Li G, Tacelosky D, Moreau M, Liu DX.

J Biol Chem. 2011 Mar 4;286(9):7705-13. doi: 10.1074/jbc.M110.207639. Epub 2011 Jan 6.

10.

Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression.

Xing Y, Wang Y, Wang S, Wang X, Fan D, Zhou D, An J.

Transl Res. 2016 Nov;177:113-126. doi: 10.1016/j.trsl.2016.06.008. Epub 2016 Jul 13.

11.

Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide.

Cates CC, Arias AD, Nakayama Wong LS, Lamé MW, Sidorov M, Cayanan G, Rowland DJ, Fung J, Karpel-Massler G, Siegelin MD, Greene LA, Angelastro JM.

Oncotarget. 2016 Mar 15;7(11):12718-30. doi: 10.18632/oncotarget.7212.

12.

Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.

Cobbs CS, Soroceanu L, Denham S, Zhang W, Britt WJ, Pieper R, Kraus MH.

J Neurooncol. 2007 Dec;85(3):271-80. Epub 2007 Jun 23.

PMID:
17589804
13.

Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis.

Cobbs CS.

Herpesviridae. 2011 Oct 26;2(1):10. doi: 10.1186/2042-4280-2-10.

14.

The endoplasmic reticulum stress transducer BBF2H7 suppresses apoptosis by activating the ATF5-MCL1 pathway in growth plate cartilage.

Izumi S, Saito A, Kanemoto S, Kawasaki N, Asada R, Iwamoto H, Oki M, Miyagi H, Ochi M, Imaizumi K.

J Biol Chem. 2012 Oct 19;287(43):36190-200. doi: 10.1074/jbc.M112.373746. Epub 2012 Aug 30.

15.

Human cytomegalovirus viral load in tumor and peripheral blood samples of patients with malignant gliomas.

Priel E, Wohl A, Teperberg M, Nass D, Cohen ZR.

J Clin Neurosci. 2015 Feb;22(2):326-30. doi: 10.1016/j.jocn.2014.06.099. Epub 2014 Oct 28.

PMID:
25443081
16.

Human cytomegalovirus gene expression in long-term infected glioma stem cells.

Fiallos E, Judkins J, Matlaf L, Prichard M, Dittmer D, Cobbs C, Soroceanu L.

PLoS One. 2014 Dec 30;9(12):e116178. doi: 10.1371/journal.pone.0116178. eCollection 2014.

17.

Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues.

Ahani N, Karimi Arzenani M, Shirkoohi R, Rokouei M, Alipour Eskandani M, Nikravesh A.

Med Oncol. 2014 Feb;31(2):812. doi: 10.1007/s12032-013-0812-4. Epub 2013 Dec 19.

PMID:
24352760
18.

Activation of telomerase by human cytomegalovirus.

Strååt K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N, Lou F, Liu Z, Shen J, Jia J, Kyo S, Björkholm M, Sjöberg J, Söderberg-Nauclér C, Xu D.

J Natl Cancer Inst. 2009 Apr 1;101(7):488-97. doi: 10.1093/jnci/djp031. Epub 2009 Mar 24.

PMID:
19318640
19.

Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells.

Yamazaki T, Ohmi A, Kurumaya H, Kato K, Abe T, Yamamoto H, Nakanishi N, Okuyama R, Umemura M, Kaise T, Watanabe R, Okawa Y, Takahashi S, Takahashi Y.

Life Sci. 2010 Aug 28;87(9-10):294-301. doi: 10.1016/j.lfs.2010.07.006. Epub 2010 Jul 21.

PMID:
20654631
20.

Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.

Angelastro JM, Canoll PD, Kuo J, Weicker M, Costa A, Bruce JN, Greene LA.

Oncogene. 2006 Feb 9;25(6):907-16.

PMID:
16170340

Supplemental Content

Support Center